EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clarithromycin Resistance Patterns of Helicobacter pylori across Different Gastric Diseases in Uzbekistan

Abrorjon Yusupbekov, Takahiro Shinozuka, Jadida Ismailova, Otabek Tuychiev, Mitsuro Kanda, Junichi Sakamoto, Yanfang Zheng

Journal of Gastrointestinal and Liver Diseases · 27.06.2026 · 35 (2) · 159-166

DOI: 10.15403/jgld-6653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 27.06.2026. Verfasst von Abrorjon Yusupbekov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (National Cancer Center of Uzbekistan), Tashkent, Uzbekistan…. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Drug Resistance, Bacterial, Clarithromycin. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Helicobacter pylori (H. pylori) eradication is crucial for gastric cancer (GC) prevention. However, increasing clarithromycin (CLR) resistance (CLRR) poses significant challenges. This study aimed to investigate CLRR patterns across different gastric diseases in Uzbekistan.

Methods

We retrospectively analyzed 279 H. pylori-infected patients with chronic non-atrophic gastritis (CNAG), chronic atrophic gastritis (CAG), gastric ulcer (GU), mucosa-associated lymphoid tissue lymphoma (MALT-L), or GC between 2020-2022. Among 194 cagA-positive patients who received eradication therapy, CLRR was defined by 23S rRNA mutations (A2142G, A2142C, A2143G) or treatment failure with CLR-based regimens. Logistic regression identified factors associated with CLRR, evaluated by univariate and multivariate analysis, and predicted probability models were generated based on disease type and patient characteristics.

Results

The overall CLRR rate was 44.8% (87/194), with 41.2% showing genotypic resistance. CLRR rates increased with disease severity: CNAG (33.3%), CAG (31.7%), GU (59.3%), MALT-L (54.1%), and GC (69.6%). Multivariate analysis identified older age (OR=2.27, 95%CI: 1.05-5.10), GU (OR=2.65, 95%CI: 1.04-6.96), and GC (OR=3.73, 95%CI: 1.34-11.2) as independent CLRR predictors. Disease-specific patterns emerged: GU and GC showed positive associations between age / body mass index and CLRR probability, while MALT-L demonstrated inverse relationships.

Conclusions

High CLRR rates in Uzbekistan correlate with gastric disease severity. The disease-specific CLRR probability patterns identified in our study provide a practical framework for optimizing empirical therapy selection when comprehensive resistance testing is unavailable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsDrug Resistance, BacterialClarithromycinAnti-Bacterial AgentsHumansUzbekistanRetrospective StudiesFemaleMaleMiddle AgedAdultAgedMutationRisk FactorsStomach UlcerGastritis, AtrophicLymphoma, B-Cell, Marginal Zone

Substanzen

ClarithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (National Cancer Center of Uzbekistan), Tashkent, Uzbekistan; Department of Oncology, Oncohematology and Medical Radiology, Tashke…
  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan. takahiroshinozuka@gmail.com.
  • Republican Specialized Scientific and Practical Center for Therapy and Medical Rehabilitation, Tashkent, Uzbekistan; Department of Internal Medicine, Tashkent State Medical University, Tashkent, Uzbekistan. jadida@list.…
  • Department of Oncology, Oncohematology and Medical Radiology, Tashkent State Medical University, Tashkent, Uzbekistan; Department of Thoracic Surgical Oncology, Republican Specialized Scientific and Practical Medical Ce…
  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan. kanda.mitsuro.v5@f.mail.nagoya-u.ac.jp.
  • Tokai Central Hospital, Kakamigahara, Japan. sakamjun@ecrin.or.jp.

Zitieren

APA

Yusupbekov, A., Shinozuka, T., Ismailova, J., Tuychiev, O., Kanda, M., Sakamoto, J., & Zheng, Y. (2026). Clarithromycin Resistance Patterns of Helicobacter pylori across Different Gastric Diseases in Uzbekistan. Journal of Gastrointestinal and Liver Diseases, 35(2), 159-166. https://doi.org/10.15403/jgld-6653

Vancouver

Yusupbekov A, Shinozuka T, Ismailova J, Tuychiev O, Kanda M, Sakamoto J, et al. Clarithromycin Resistance Patterns of Helicobacter pylori across Different Gastric Diseases in Uzbekistan. Journal of Gastrointestinal and Liver Diseases. 2026;35(2):159-166. doi:10.15403/jgld-6653

BibTeX
@article{Yusupbekov2026,
  author = {Yusupbekov, Abrorjon and Shinozuka, Takahiro and Ismailova, Jadida and Tuychiev, Otabek and Kanda, Mitsuro and Sakamoto, Junichi and Zheng, Yanfang},
  title = {Clarithromycin Resistance Patterns of Helicobacter pylori across Different Gastric Diseases in Uzbekistan},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2026},
  volume = {35},
  number = {2},
  pages = {159--166},
  doi = {10.15403/jgld-6653}
}
Kostenlos starten →